HomePharma

Pharma

Pharma

Silence Therapeutics Presents New Analysis from SLN360 Phase 1 Single Dose Study in High Lipoprotein(a)

Life Sciences Times - 0
Pharma

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis

Life Sciences Times - 0
Pharma

U.S. Food and Drug Administration Approves Vemlidy® (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients

Life Sciences Times - 0
Pharma

Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

Life Sciences Times - 0
Pharma

Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial

Life Sciences Times - 0
Pharma

Takeda Becomes First Enterprise to Achieve Diamond Tier Status as a Best in Resilience™ Certified Organization

Life Sciences Times - 0
Pharma

Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce First Paragraph IV Filing and Acceptance by FDA

Life Sciences Times - 0
Pharma

Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities

Life Sciences Times - 0
Pharma

Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol® for the Treatment of Dry Eye Disease

Life Sciences Times - 0
Pharma

Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® Tablets for the Treatment of Chorea Associated with Huntington’s Disease

Life Sciences Times - 0
Pharma

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for Cholestatic Pruritus

Life Sciences Times - 0
Pharma

CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares

Life Sciences Times - 0
1...464748...91Page 47 of 91

Most Read